ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,307, issued on March 25, was assigned to Diverse Biotech Inc. (Miami).
"Beta-lactam-cannabinoid conjugate molecules" was invented by Paul Hershberger (Orlando, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides multifunctional conjugate molecules in which at least one Beta-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the Beta-lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections a...